Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Serum Anti-Mullerian Hormone (AMH) Levels Among Different PCOS Phenotypes and Its Correlation with Clinical, Endocrine, and Metabolic Markers of PCOS.

Reproductive sciences (Thousand Oaks, Calif.) - 1 Aug 2023

Malhotra Neena, Mahey Reeta, Cheluvaraju Rohitha, Rajasekaran Keerthana, Patkar Deeksha, Prabhakar Priyanka, Rajput Monika, Upadhyay Ashish

Abstract excerpt

Anti-Mullerian hormone (AMH) is one of the direct indicators of follicular pool but no standard cutoff has been defined for diagnosis of polycystic ovary syndrome (PCOS). The present study evaluated the serum AMH levels among different PCOS phenotypes and correlated the AMH levels with clinical, hormonal, and metabolic parameters among Indian PCOS women. Mean serum AMH was 12.39 ± 5.3ng/mL in PCOS cohort and 3.83...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Mullerian Hormone
Share to Ovarian Follicle

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Phenotype

Share to Polycystic Ovary Syndrome

Source

Identifiers

PMID: 36862325
DOI: 10.1007/s43032-023-01195-y

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Serum Anti-Mullerian Hormone (AMH) Levels Among Different PCOS Phenotypes and Its Correlation with Clinical, Endocrine, and Metabolic Markers of PCOS.PMID 36862325Read ↗

The Relationship of Anti-Mullerian Hormone in Polycystic Ovary Syndrome Patients With Different SubgroupsSemantic proximity Read ↗

Association between anti‐Müllerian hormone levels and polycystic ovary syndrome in a general cohort of young women in JapanSemantic proximity Read ↗

The Role of Anti-Müllerian Hormone in the Characterization of the Different Polycystic Ovary Syndrome Phenotypes.Semantic proximity Read ↗

Serum anti-Müllerian hormone and insulin resistance in the main phenotypes of non-obese polycystic ovarian syndrome women in China.Semantic proximity Read ↗

The correlation between serum AMH and HOMA-IR among PCOS phenotypes.Semantic proximity Read ↗

Serum anti-Mullerian hormone levels in the main phenotypes of polycystic ovary syndrome.Semantic proximity Read ↗

AMH levels and diagnosis in PCOS phenotype D.Semantic proximity Read ↗

Comparison of clinical and hormonal characteristics among four phenotypes of polycystic ovary syndrome based on the Rotterdam criteria.Semantic proximity Read ↗

Cardio-metabolic risk in Rotterdam clinical phenotypes of PCOS.Semantic proximity Read ↗

Elevated Anti-Müllerian Hormone as a Prognostic Factor for Poor Outcomes of In Vitro Fertilization in Women with Polycystic Ovary SyndromeSemantic proximity Read ↗

Phenotypic variation in anti-Mullerian hormone (AMH) production per follicle in women with polycystic ovary syndrome (PCOS) and isolated polycystic ovarian morphology (PCOM): an observational cross-sectional study.Semantic proximity Read ↗

Correlation of Homeostatic Model Assessment-Insulin Resistance, Anti-Mullerian Hormone, and BMI in the Characterization of Polycystic Ovary SyndromeSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.